Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Seroma
Interventions: DRUG: extended release of octreotide|DRUG: extended release of placebo
Sponsor: Chemi S.p.A.